In vitro testing of drug-induced systemic hypersensitivity: Just a burden or an opportunity?

Khan, 2010, Drug allergy, J Allergy Clin Immunol, 125, S126, 10.1016/j.jaci.2009.10.028 Sachs, 2002, Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization, Clin Exp Allergy, 32, 736, 10.1046/j.1365-2222.2002.01382.x Torres, 2003, ENDA, EAACI Interest Group on Drug hypersensitivity, Diagnosis of immediate allergic reactions to beta-lactam antibiotics, Allergy, 58, 961, 10.1034/j.1398-9995.2003.00280.x Romano, 2004, Diagnosis of nonimmediate reactions to beta-lactam antibiotics, Allergy, 59, 1553, 10.1111/j.1398-9995.2004.00678.x Sachs, 2004, Clinical and laboratory investigations. Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillin instead of challenge with culprit drugs, Br J Dermatol, 151, 809, 10.1111/j.1365-2133.2004.06238.x Warbrick, 2001, Prediction of drug allergenicity: possible use of the local lymph node assay, Curr Opin Drug Discov Devel, 4, 60 Pieters, 2001, The popliteal lymph node assay: a tool for predicting drug allergies, Toxicology, 158, 65, 10.1016/S0300-483X(00)00409-1 Albers, 1997, The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals, Toxicol Appl Pharmacol, 143, 102, 10.1006/taap.1996.8078 Ravel, 2005, Popliteal lymph node assay: facts and perspectives, J Appl Toxicol, 25, 451, 10.1002/jat.1072 Gruchalla, 2001, Drug metabolism, danger signals, and drug-induced hypersensitivity, J allergy Clin Immunol, 108, 475, 10.1067/mai.2001.118509 Pichler, 2003, Drug-induced autoimmunity, Curr Opin Allergy Clin Immunol, 3, 249, 10.1097/00130832-200308000-00003 Pieters, 2007, Detection of autoimmunity by pharmaceuticals, Methods, 41, 112, 10.1016/j.ymeth.2006.09.005 Corti, 2015, Optimization of the THP-1 activation assay to detect pharmaceuticals with potential to cause immune mediated drug reactions, Toxicol In Vitro, 29, 1339, 10.1016/j.tiv.2015.04.012 Weltzien, 1996, T cell immune responses to haptens. Structural models for allergic and autoimmune reactions, Toxicology, 107, 141, 10.1016/0300-483X(95)03253-C Pichler, 2002, Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept, Curr Opin Allergy Clin Immunol, 2, 301, 10.1097/00130832-200208000-00003 Mayorga, 2016, In vitro tests for drug hypersensitivity reactions, an ENDA/EAACI Drug Allergy Interest Group position paper, Allergy, 10.1111/all.12886 Philipps, 2006, The pharmacogenetics of antiretroviral therapy, Curr Opin HIV AIDS, 1, 249, 10.1097/01.COH.0000221600.64659.d3 Mallal, 2008, HLA-B*5701 screening for hypersensitivity to abacavir, N Engl J Med, 358, 568, 10.1056/NEJMoa0706135 Martin, 2010, T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assay, Cell Mol Life Sci, 67, 4171, 10.1007/s00018-010-0495-3 Hammond, 2007, External quality assessment of HLA-B*5701 reporting: an international multicentre survey, Antivir Ther, 12, 1027, 10.1177/135965350701200708 Nyfeler, 1997, The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specific, Clin Exp Allergy, 27, 175, 10.1111/j.1365-2222.1997.tb00690.x Lanzavecchia, 2000, Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells, Science, 290, 92, 10.1126/science.290.5489.92 Romano, 1997, Diagnostic evaluation of delayed hypersensitivity to systematically administered drugs, Allergy, 27, 175 Beeler, 2007, In vitro tests of T-cell mediated drug hypersensitivity, 380 Sullivan, 2015, Are drug metabolites able to cause T-cell mediated hypersensitivity reactions?, Expert Opin Drug Metab Toxicol, 11, 357, 10.1517/17425255.2015.992780 Zawodniak, 2010, In vitro detection of cytotoxic T and NK cells in peripheral blood of patient with various drug-induced skin diseases, Allergy, 65, 376, 10.1111/j.1398-9995.2009.02180.x Porebski, 2013, In vitro drug causality assessment in Stevenson-Johnson syndrome – alternatives for lymphocyte transformation test, Clin Exp Allergy, 43, 1027, 10.1111/cea.12145 Khalil, 2008, Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin, Eur Cytokine Netw, 19, 131 Beeler, 2008, CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity, Allergy, 62, 181 Mayorga, 2006, Monitoring the acute phase response in non-immediate allergic drug reactions, Curr Opin Allergy Clin Immunol, 6, 249, 10.1097/01.all.0000235897.72429.4a Niwa, 2000, Evidence of degradation of cytokines in the serum of patients with atopic dermatitis by calcium-dependent protease, Arch Dermatol Res, 292, 391, 10.1007/s004030000148 Mirakian, 2009, BSACI guidelines for the management of drug allergy, Clin Exp Allergy, 39, 43, 10.1111/j.1365-2222.2008.03155.x Dietz, 2010, Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactivity small chemicals to chemical-specific naïve human T-cell priming, Toxicol Sci, 117, 336, 10.1093/toxsci/kfq209 Martin, 2006, A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome, Pharmacogenet Genomics, 16, 353, 10.1097/01.fpc.0000197468.16126.cd Richter, 2013, Human T cell priming assay (hTCPA) for the identification of contact allergens based on naïve T cell and DC-IFN- γ and TNF- α readout, Toxicol In Vitro, 27, 1180, 10.1016/j.tiv.2012.08.007 Urbisch, 2015, Assessing skin sensitization hazard in mice and men using non-animal test methods, Regul Toxicol Pharmacol, 71, 337, 10.1016/j.yrtph.2014.12.008 Bauch, 2012, Putting the parts together: combining in vitro methods to test for skin sensitizing potentials, Regul Toxicol Pharmacol, 63, 489, 10.1016/j.yrtph.2012.05.013 Natsch, 2011, The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: Results of a ring-study in five laboratories, Toxic In Vitro, 25, 733, 10.1016/j.tiv.2010.12.014 Nukada, 2012, Prediction of skin sensitization potency of chemicals by human cell line activation test (h-CLAT) and an attempt at classifying skin sensitization potency, Toxicol In Vitro, 26, 1150, 10.1016/j.tiv.2012.07.001 Takenouchi, 2013, Predictive performance of the human Cell Line Activation Test (h-CLAT) for lipophilic chemicals with high octanol-water partition coefficients, J Toxicol Sci, 38, 599, 10.2131/jts.38.599 Mitjans, 2008, Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THp-1 cells, Toxicol In Vitro, 22, 386, 10.1016/j.tiv.2007.10.005 Mitjans, 2010, Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro, Toxicol In Vitro, 24, 1803, 10.1016/j.tiv.2010.06.001 Weaver, 2005, Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions, J Immunotoxicol, 2, 11, 10.1080/15476910590930100 Siegel, 1957, Studies in penicillin hypersensitivity. IV. Antigenic properties of altered procaine penicillin, J Allergy, 28, 264